TREATMENT OF SIDE EFFECTS IN THE FORM OF MOTOR AND MOTOR DISORDERS RELATED TO THE TREATMENT OF PARKINSON'S DISEASE

摘要

1. A method of treating a side effect of a motor disorder associated with administering levodopa to a patient having Parkinson's disease, the method comprising: administering to said patient in need of treatment a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof to reduce said side effect as motor disorder, wherein said eltoprazine is administered at a dose of about 0.25 mg / day to about 25 mg / day. The method of claim 1, wherein said side effect of a motor disorder is dyskinesia. The method of claim 1, further comprising administering carbidopa. 4. The method of claim 1, wherein said eltoprazine is administered at a dose of from about 2.5 mg / day to about 10 mg / day. The method according to claim 4, wherein said eltoprazine is administered at a dose of about 2.5 mg / day. The method of claim 4, wherein said eltoprazine is administered at a dose of about 5.0 mg / day. The method of claim 4, wherein said eltoprazine is administered at a dose of about 7.5 mg / day. The method of claim 4, wherein said eltoprazine is administered at a dose of about 10 mg / day. The method of claim 1, wherein said patient is a human. A method according to claim 1 or 9, wherein said administration of eltoprazine does not reduce the effectiveness of said administration of levodopa. A method of treating Parkinson’s disease in a person in need thereof, the method comprising administering to said person a dose of levodopa and a dose of eltoprazine or a pharmaceutically acceptable acid addition salt thereof, wherein said eltoprazine is administered at a dose of from about 0.25 mg / day to about 25 mg / day 12. The method of claim 11, further comprising administering carbidopa. The method of claim 11, wherein said eltoprazine and said levodopa are both active in said